After a varied career in research and development, commercial and entrepreneurial business roles, Jeff joined Shire in July 2008 as leader of the specialty pharmaceuticals R&D team.
Jeff has been closely involved with the regenerative medicine business since Shire acquired it as Advanced BioHealing in June 2011.
Jeff’s previous role as head of the SP R&D team will be filled by Arnaud Partiot. Arnaud is a qualified psychiatrist and has been a senior member of the Shire SP team in various clinical research & development, medical affairs and commercial roles since joining Shire in 2004.
Kevin Rakin, who led Advanced BioHealing since 2007 and during its integration into Shire, is stepping down from his position as regenerative medicine president and from the Shire leadership team to pursue new career interests.